Advanced Medical Solutions Group (LON:AMS) Shares Cross Above 200 Day Moving Average – Here’s What Happened

Advanced Medical Solutions Group plc (LON:AMS)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 214.78 and traded as high as GBX 216. Advanced Medical Solutions Group shares last traded at GBX 215.50, with a volume of 698,114 shares.

Analysts Set New Price Targets

Separately, Berenberg Bank restated a “buy” rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Advanced Medical Solutions Group presently has an average rating of “Buy” and a consensus price target of GBX 273.67.

Advanced Medical Solutions Group Price Performance

The business’s 50-day simple moving average is GBX 217.36 and its two-hundred day simple moving average is GBX 214.78. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The firm has a market cap of £461.98 million, a price-to-earnings ratio of 51.20, a P/E/G ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.